EP1024810A4 - Method for optimizing retinal and optic nerve health - Google Patents
Method for optimizing retinal and optic nerve healthInfo
- Publication number
- EP1024810A4 EP1024810A4 EP98931510A EP98931510A EP1024810A4 EP 1024810 A4 EP1024810 A4 EP 1024810A4 EP 98931510 A EP98931510 A EP 98931510A EP 98931510 A EP98931510 A EP 98931510A EP 1024810 A4 EP1024810 A4 EP 1024810A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- optic nerve
- nerve health
- retinal
- optimizing
- optimizing retinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5083597P | 1997-06-26 | 1997-06-26 | |
US50835 | 1997-06-26 | ||
GB9800449 | 1998-01-09 | ||
GBGB9800449.2A GB9800449D0 (en) | 1998-01-09 | 1998-01-09 | Method for optimizing retinal and optic nerve health |
PCT/US1998/013038 WO1999000133A1 (en) | 1997-06-26 | 1998-06-22 | Method for optimizing retinal and optic nerve health |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1024810A1 EP1024810A1 (en) | 2000-08-09 |
EP1024810A4 true EP1024810A4 (en) | 2003-06-11 |
Family
ID=26312917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98931510A Withdrawn EP1024810A4 (en) | 1997-06-26 | 1998-06-22 | Method for optimizing retinal and optic nerve health |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1024810A4 (en) |
JP (1) | JP2002506461A (en) |
AU (1) | AU740874B2 (en) |
CA (1) | CA2294343A1 (en) |
WO (1) | WO1999000133A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948801A (en) * | 1998-03-09 | 1999-09-07 | Alcon Laboratories, Inc. | Treatment of retinal edema with brinzolamide |
US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
US6174524B1 (en) | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
ATE243038T1 (en) | 1999-11-01 | 2003-07-15 | Alcon Inc | PHARMACEUTICAL COMPOSITIONS CONTAINING A FLUOROCHINOLONE ANTIBIOTIC AND XANTHANG GUM |
BR0112787B1 (en) | 2000-07-28 | 2013-03-05 | topically administrable solution composition. | |
KR100883077B1 (en) | 2001-04-11 | 2009-02-10 | 센주 세이야꾸 가부시키가이샤 | Visual function disorder improving agents |
WO2006035969A1 (en) * | 2004-09-28 | 2006-04-06 | Senju Pharmaceutical Co., Ltd. | Ophthalmic composition containing xanthan gum and amino acid |
JP4966854B2 (en) | 2005-07-11 | 2012-07-04 | 千寿製薬株式会社 | Eye drops containing xanthan gum and terpenoids |
KR101381035B1 (en) | 2006-03-23 | 2014-04-04 | 센주 세이야꾸 가부시키가이샤 | Ophthalmic composition comprising xanthan gum and glucose |
WO2008075155A2 (en) | 2006-12-15 | 2008-06-26 | Nicox S.A. | Carbonic anhydrase inhibitors derivatives |
US8222156B2 (en) | 2006-12-29 | 2012-07-17 | Lam Research Corporation | Method and apparatus for processing a substrate using plasma |
JP5305710B2 (en) * | 2008-03-31 | 2013-10-02 | 株式会社ニデック | Dorzolamide hydrochloride ophthalmic solution |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0033042A1 (en) * | 1980-01-28 | 1981-08-05 | Merck & Co. Inc. | Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors |
EP0036351A2 (en) * | 1980-03-04 | 1981-09-23 | Merck & Co. Inc. | Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure |
EP0507224A2 (en) * | 1991-03-27 | 1992-10-07 | Alcon Laboratories, Inc. | Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
WO1993016701A2 (en) * | 1992-02-21 | 1993-09-02 | Alcon Laboratories, Inc. | Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
EP0590786A1 (en) * | 1992-08-28 | 1994-04-06 | Alcon Laboratories, Inc. | Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions |
WO1996037203A1 (en) * | 1995-05-22 | 1996-11-28 | Advanced Research & Technology Institute | Method to increase retinal blood flow |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378703A (en) * | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
-
1998
- 1998-06-22 EP EP98931510A patent/EP1024810A4/en not_active Withdrawn
- 1998-06-22 WO PCT/US1998/013038 patent/WO1999000133A1/en not_active Application Discontinuation
- 1998-06-22 CA CA002294343A patent/CA2294343A1/en not_active Abandoned
- 1998-06-22 AU AU81622/98A patent/AU740874B2/en not_active Ceased
- 1998-06-22 JP JP50566199A patent/JP2002506461A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0033042A1 (en) * | 1980-01-28 | 1981-08-05 | Merck & Co. Inc. | Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors |
EP0036351A2 (en) * | 1980-03-04 | 1981-09-23 | Merck & Co. Inc. | Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure |
EP0507224A2 (en) * | 1991-03-27 | 1992-10-07 | Alcon Laboratories, Inc. | Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
WO1993016701A2 (en) * | 1992-02-21 | 1993-09-02 | Alcon Laboratories, Inc. | Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
EP0590786A1 (en) * | 1992-08-28 | 1994-04-06 | Alcon Laboratories, Inc. | Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions |
WO1996037203A1 (en) * | 1995-05-22 | 1996-11-28 | Advanced Research & Technology Institute | Method to increase retinal blood flow |
Non-Patent Citations (3)
Title |
---|
CHIOU G C Y ET AL: "EFFECTS OF ANTIGLAUCOMA DRUGS ON OCULAR BLOOD FLOW IN OCULAR HYPERTENSIVE RABBITS", JOURNAL OF OCULAR PHARMACOLOGY, MARY ANN LIEBERT, INC. NEW YORK, NY, US, vol. 9, no. 1, 21 March 1993 (1993-03-21), pages 13 - 24, XP000993431, ISSN: 8756-3320 * |
RASSAM S M B ET AL: "THE EFFECT OF ACETAZOLAMIDE ON THE RETINAL CIRCULATION", EYE, ROYAL COLLEGE OF OPHTALMOLOGISTS, LONDON, GB, vol. 7, no. PART 5, 1993, pages 697 - 702, XP002059279 * |
See also references of WO9900133A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2294343A1 (en) | 1999-01-07 |
AU740874B2 (en) | 2001-11-15 |
AU8162298A (en) | 1999-01-19 |
EP1024810A1 (en) | 2000-08-09 |
WO1999000133A1 (en) | 1999-01-07 |
JP2002506461A (en) | 2002-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL134868A0 (en) | A method for maintaining or improving skin health | |
AU7383398A (en) | Therapeutic glasses and method for using the same | |
EP0789592A4 (en) | Ocular gene therapy | |
IL113723A0 (en) | An eye implant | |
IL131821A0 (en) | Defibrillator apparatus and method | |
GB9518888D0 (en) | Device and method for transcutaneous surgery | |
GB0015133D0 (en) | Formation treatment method using deformable particles | |
EP1024810A4 (en) | Method for optimizing retinal and optic nerve health | |
GB9410320D0 (en) | Novel therapeutic method | |
GB9719161D0 (en) | New therapeutic method | |
AU6242498A (en) | Methods for treating central and peripheral nerve pain | |
AU3206195A (en) | Optic nerve health | |
AUPP618098A0 (en) | Apparatus and method for avoiding ocular muscular fatigue | |
GB9515868D0 (en) | Therapeutic method | |
GB2290096B (en) | Oil well treatment | |
GB9714841D0 (en) | Treatment method | |
ZA982579B (en) | Method of stimulating nerve regeneration | |
EP0697189A4 (en) | Eyeball observing apparatus | |
GB9800449D0 (en) | Method for optimizing retinal and optic nerve health | |
GB9708400D0 (en) | Sterilising arrangement and method | |
ZA987960B (en) | Methods for treating ocular diseases | |
GB9507848D0 (en) | Fatigue related diseases | |
AUPO943497A0 (en) | Apparatus and method for avoiding ocular muscular fatigue | |
GB9719176D0 (en) | New therapeutic method | |
GB9719189D0 (en) | New therapeutic method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000126 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030429 |
|
17Q | First examination report despatched |
Effective date: 20031106 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040317 |